| Schedule of Segment Information |
The following is the summary of the financial information for the Company’s reportable segments for the three and six months ended March 31, 2026 and 2025 (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended March 31, | | Six Months Ended March 31, | | 2026 | | 2025 | | 2026 | | 2025 | | Revenue: | | | | | | | | | Sample Management Solutions | $ | 81,091 | | | $ | 79,816 | | | $ | 162,515 | | | $ | 160,954 | | | Multiomics | 63,704 | | | 63,522 | | | 130,922 | | | 129,820 | | | Total revenue | $ | 144,795 | | | $ | 143,338 | | | $ | 293,437 | | | $ | 290,774 | | | | | | | | | | | Adjusted operating income (loss): | | | | | | | | | Sample Management Solutions | $ | 3,115 | | | $ | 2,809 | | | $ | 8,092 | | | $ | 7,580 | | | Multiomics | (10,067) | | | (5,536) | | | (14,427) | | | (7,843) | | | Segment adjusted operating loss | $ | (6,952) | | | $ | (2,727) | | | $ | (6,335) | | | $ | (263) | | | | | | | | | | | Amortization of completed technology | 2,076 | | | 2,308 | | | 3,935 | | | 3,808 | | | Amortization of other intangible assets | 3,563 | | | 3,803 | | | 7,113 | | | 8,376 | | Transformation costs (1) | 440 | | | 5,183 | | | 1,642 | | | 8,229 | | | Restructuring charges | 1,422 | | | 3,580 | | | 2,565 | | | 4,011 | | | Impairment of goodwill and intangible assets | 149,083 | | | — | | | 149,083 | | | — | | Merger and acquisition costs (2) | 2,175 | | | 688 | | | 2,188 | | | 2,258 | | | Other miscellaneous expenses | 79 | | | (95) | | | 166 | | | (50) | | | Total operating loss | (165,790) | | | (18,194) | | | (173,027) | | | (26,895) | | | Interest income, net | 4,387 | | | 4,489 | | | 9,485 | | | 8,787 | | | Other income, net | 4,059 | | | 1,158 | | | 4,138 | | | 2,362 | | | Loss from continuing operations before income taxes | $ | (157,344) | | | $ | (12,547) | | | $ | (159,404) | | | $ | (15,746) | |
(1)Transformation costs represent non-recurring expenses for strategic projects with anticipated long-term benefits to the Company focused on cost reduction and productivity improvement that do not meet the definition of restructuring charges. These costs are directed at simplifying, standardizing, streamlining, and optimizing the Company’s operations, processes and systems to permanently alter the Company’s operations for the long term. For a project to be considered transformational, successful completion of the project must be expected to bring long-term material benefits to the organization and involve significant changes to process and/or underlying technology. Transformation costs primarily relate to one time asset write downs associated with changes in technology, one-time inventory write downs relating to restructuring actions, and third-party consulting costs associated with process and systems re-design. (2)Includes expenses related to governance-related matters. | | | | | | | | | | | | | | | | | | | | | | | | | Sample Management Solutions | Three Months Ended March 31, | | Six Months Ended March 31, | | 2026 | | 2025 | | 2026 | | 2025 | | | | | | | | | | Total revenue | $ | 81,091 | | | $ | 79,816 | | | $ | 162,515 | | | $ | 160,954 | | | Less: Adjusted cost of revenue | 42,618 | | | 42,229 | | | 87,083 | | | 83,524 | | | Less: Adjusted operating expenses | 35,358 | | | 34,778 | | | 67,340 | | | 69,850 | | | Adjusted operating income | $ | 3,115 | | | $ | 2,809 | | | $ | 8,092 | | | $ | 7,580 | | | | | | | | | | | Other Information | | | | | | | | | Depreciation Expense | $ | 3,317 | | | $ | 2,914 | | | $ | 6,448 | | | $ | 5,552 | |
| | | | | | | | | | | | | | | | | | | | | | | | | Multiomics | Three Months Ended March 31, | | Six Months Ended March 31, | | 2026 | | 2025 | | 2026 | | 2025 | | | | | | | | | | Total revenue | $ | 63,704 | | | $ | 63,522 | | | $ | 130,922 | | | $ | 129,820 | | | Less: Adjusted cost of revenue | 38,066 | | | 36,027 | | | 76,678 | | | 71,788 | | | Less: Adjusted operating expenses | 35,705 | | | 33,031 | | | 68,671 | | | 65,875 | | | Adjusted operating loss | $ | (10,067) | | | $ | (5,536) | | | $ | (14,427) | | | $ | (7,843) | | | | | | | | | | | Other Information | | | | | | | | | Depreciation Expense | $ | 3,955 | | | $ | 3,649 | | | $ | 7,940 | | | $ | 7,322 | |
|
| Schedule of Segment Assets |
The following is the summary of the asset information for the Company’s reportable segments as of March 31, 2026 and September 30, 2025 (in thousands): | | | | | | | | | | | | | Assets: | March 31, 2026 | | September 30, 2025 | | Sample Management Solutions | $ | 817,808 | | | $ | 854,402 | | | Multiomics | 322,731 | | | 445,212 | | | Total assets | $ | 1,140,539 | | | $ | 1,299,614 | |
The following is a reconciliation of the segment assets to the corresponding amounts presented in the Condensed Consolidated Balance Sheets as of March 31, 2026 and September 30, 2025 (in thousands): | | | | | | | | | | | | | March 31, 2026 | | September 30, 2025 | | Segment assets | $ | 1,140,539 | | | $ | 1,299,614 | | | Cash and cash equivalents, restricted cash and marketable securities | 564,840 | | | 546,201 | | | Deferred tax assets | 501 | | | 726 | | | General corporate assets | 52,459 | | | 54,500 | | | Current and noncurrent assets held for sale | 145,550 | | | 158,541 | | | Total assets | $ | 1,903,889 | | | $ | 2,059,582 | |
|
| Schedule of Revenue by Geographic Area |
Net revenue by geographic area for the three and six months ended March 31, 2026 and 2025 are as follows (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended March 31, | | Six Months Ended March 31, | | 2026 | | 2025 | | 2026 | | 2025 | | Geographic Location: | | | | | | | | | United States | $ | 83,024 | | | $ | 89,937 | | | $ | 170,437 | | | $ | 183,403 | | | China | 16,892 | | | 12,739 | | | 34,824 | | | 27,626 | | | United Kingdom | 10,397 | | | 8,011 | | | 20,386 | | | 15,738 | | | Rest of Europe | 25,869 | | | 25,259 | | | 52,370 | | | 49,578 | | | Asia Pacific (Excluding China) | 7,528 | | | 6,371 | | | 13,210 | | | 12,077 | | | Other | 1,085 | | | 1,021 | | | 2,210 | | | 2,352 | | | Total revenue | $ | 144,795 | | | $ | 143,338 | | | $ | 293,437 | | | $ | 290,774 | |
|
| Schedule of Long-lived Assets by Geographic Area |
Net long-lived assets, excluding goodwill and other intangible assets, by geographic area as of March 31, 2026 and September 30, 2025 (in thousands): | | | | | | | | | | | | | March 31, 2026 | | September 30, 2025 | | United States | $ | 116,187 | | | $ | 116,681 | | | China | 57,681 | | | 56,715 | | | Europe | 15,272 | | | 16,674 | | | United Kingdom | 38,943 | | | 14,338 | | | Asia Pacific (Excluding China) | 3,146 | | | 3,505 | | | Other | 54 | | | 89 | | | Total long-lived assets, net | $ | 231,283 | | | $ | 208,002 | |
|